Skip to main content

August 2011 Vol 4, No 4, Special Issue

Economic Recession Affects Rates of Cancer Incidence and Treatment
Wayne Kuznar
Read More
Value of Targeted Therapies in Patients Lacking a Molecular Target Questioned
Caroline Helwick
Read More
Most End-of-Life Costs for Patients with Cancer Are Not Drug-Related
Read More
Bankruptcy Rates Markedly Greater for Cancer Survivors
Read More
Inappropriate Antineoplastic Agents Use for Metastatic Cancer Costs Insurers Millions
Read More
Multiple Myeloma, Oncology
Multiple Myeloma Treatments Are Moving Rapidly from Bench to Bedside
Wayne Kuznar
Read More
Perspectives
What Do Payers Want in Oncology Diagnostics? Insights from a National Survey of Top Commercial and Medicare Health Plans
Gene Trogan, PhD
Read More
Original Research
New Standard of Care for Childhood Neuroblastoma
Read More
Assay Can Streamline Use of Temozolomide in Glioblastoma
Read More
Original Research
JAK Inhibitor Improves Response, Symptoms in Patients with High-Risk Myelofibrosis
Read More
Page 1 of 3
Results 1 - 10 of 30